Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes

In recent years, SGLT2 inhibitors have become an integral part of heart failure therapy, and several mechanisms contributing to cardiorenal protection have been identified. In this study, we place special emphasis on the atria and investigate acute electrophysiological effects of dapagliflozin to as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Paasche, Amelie (VerfasserIn) , Wiedmann, Felix Tobias (VerfasserIn) , Kraft, Manuel (VerfasserIn) , Seibertz, Fitzwilliam (VerfasserIn) , Herlt, Valerie (VerfasserIn) , Blochberger, Pablo L. (VerfasserIn) , Jávorszky, Natasa (VerfasserIn) , Beck, Moritz (VerfasserIn) , Weirauch, Leo (VerfasserIn) , Seeger, Timon (VerfasserIn) , Blank, Antje (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Arif, Rawa (VerfasserIn) , Meyer, Anna L. (VerfasserIn) , Warnecke, Gregor (VerfasserIn) , Karck, Matthias (VerfasserIn) , Voigt, Niels (VerfasserIn) , Frey, Norbert (VerfasserIn) , Schmidt, Constanze (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 03 January 2024
In: Basic research in cardiology
Year: 2024, Jahrgang: 119, Heft: 1, Pages: 93-112
ISSN:1435-1803
DOI:10.1007/s00395-023-01022-0
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00395-023-01022-0
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00395-023-01022-0
Volltext
Verfasserangaben:Amelie Paasche, Felix Wiedmann, Manuel Kraft, Fitzwilliam Seibertz, Valerie Herlt, Pablo L. Blochberger, Natasa Jávorszky, Moritz Beck, Leo Weirauch, Timon Seeger, Antje Blank, Walter E. Haefeli, Rawa Arif, Anna L. Meyer, Gregor Warnecke, Matthias Karck, Niels Voigt, Norbert Frey, Constanze Schmidt

MARC

LEADER 00000caa a2200000 c 4500
001 1883339758
003 DE-627
005 20240703153350.0
007 cr uuu---uuuuu
008 240313s2024 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00395-023-01022-0  |2 doi 
035 |a (DE-627)1883339758 
035 |a (DE-599)KXP1883339758 
035 |a (OCoLC)1443645588 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Paasche, Amelie  |e VerfasserIn  |0 (DE-588)1258391082  |0 (DE-627)1804367095  |4 aut 
245 1 0 |a Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes  |c Amelie Paasche, Felix Wiedmann, Manuel Kraft, Fitzwilliam Seibertz, Valerie Herlt, Pablo L. Blochberger, Natasa Jávorszky, Moritz Beck, Leo Weirauch, Timon Seeger, Antje Blank, Walter E. Haefeli, Rawa Arif, Anna L. Meyer, Gregor Warnecke, Matthias Karck, Niels Voigt, Norbert Frey, Constanze Schmidt 
264 1 |c 03 January 2024 
300 |a 20 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.03.2024 
520 |a In recent years, SGLT2 inhibitors have become an integral part of heart failure therapy, and several mechanisms contributing to cardiorenal protection have been identified. In this study, we place special emphasis on the atria and investigate acute electrophysiological effects of dapagliflozin to assess the antiarrhythmic potential of SGLT2 inhibitors. Direct electrophysiological effects of dapagliflozin were investigated in patch clamp experiments on isolated atrial cardiomyocytes. Acute treatment with elevated-dose dapagliflozin caused a significant reduction of the action potential inducibility, the amplitude and maximum upstroke velocity. The inhibitory effects were reproduced in human induced pluripotent stem cell-derived cardiomyocytes, and were more pronounced in atrial compared to ventricular cells. Hypothesizing that dapagliflozin directly affects the depolarization phase of atrial action potentials, we examined fast inward sodium currents in human atrial cardiomyocytes and found a significant decrease of peak sodium current densities by dapagliflozin, accompanied by a moderate inhibition of the transient outward potassium current. Translating these findings into a porcine large animal model, acute elevated-dose dapagliflozin treatment caused an atrial-dominant reduction of myocardial conduction velocity in vivo. This could be utilized for both, acute cardioversion of paroxysmal atrial fibrillation episodes and rhythm control of persistent atrial fibrillation. In this study, we show that dapagliflozin alters the excitability of atrial cardiomyocytes by direct inhibition of peak sodium currents. In vivo, dapagliflozin exerts antiarrhythmic effects, revealing a potential new additional role of SGLT2 inhibitors in the treatment of atrial arrhythmias. 
650 4 |a Atrial action potential 
650 4 |a Atrial fibrillation 
650 4 |a Dapagliflozin 
650 4 |a NaV1.5 
650 4 |a SGLT2 inhibitors 
700 1 |a Wiedmann, Felix Tobias  |d 1987-  |e VerfasserIn  |0 (DE-588)1055852441  |0 (DE-627)792733479  |0 (DE-576)411904159  |4 aut 
700 1 |a Kraft, Manuel  |d 1989-  |e VerfasserIn  |0 (DE-588)1189344831  |0 (DE-627)1668018667  |4 aut 
700 1 |a Seibertz, Fitzwilliam  |e VerfasserIn  |4 aut 
700 1 |a Herlt, Valerie  |e VerfasserIn  |0 (DE-588)1323337652  |0 (DE-627)1883343399  |4 aut 
700 1 |a Blochberger, Pablo L.  |e VerfasserIn  |0 (DE-588)1258391805  |0 (DE-627)1804368075  |4 aut 
700 1 |a Jávorszky, Natasa  |d 1996-  |e VerfasserIn  |0 (DE-588)1258396971  |0 (DE-627)1804368970  |4 aut 
700 1 |a Beck, Moritz  |e VerfasserIn  |0 (DE-588)1175650757  |0 (DE-627)1046939653  |0 (DE-576)51637382X  |4 aut 
700 1 |a Weirauch, Leo  |e VerfasserIn  |0 (DE-588)1323338195  |0 (DE-627)1883344050  |4 aut 
700 1 |a Seeger, Timon  |d 1979-  |e VerfasserIn  |0 (DE-588)135748178  |0 (DE-627)693749148  |0 (DE-576)284473766  |4 aut 
700 1 |a Blank, Antje  |e VerfasserIn  |0 (DE-588)1061215962  |0 (DE-627)805162364  |0 (DE-576)174275722  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Arif, Rawa  |d 1984-  |e VerfasserIn  |0 (DE-588)1023582775  |0 (DE-627)718414071  |0 (DE-576)367034530  |4 aut 
700 1 |a Meyer, Anna L.  |d 1977-  |e VerfasserIn  |0 (DE-588)130213896  |0 (DE-627)495058912  |0 (DE-576)298066866  |4 aut 
700 1 |a Warnecke, Gregor  |d 1974-  |e VerfasserIn  |0 (DE-588)125001517  |0 (DE-627)370699629  |0 (DE-576)294612823  |4 aut 
700 1 |a Karck, Matthias  |d 1961-  |e VerfasserIn  |0 (DE-588)130833525  |0 (DE-627)505909340  |0 (DE-576)298366169  |4 aut 
700 1 |a Voigt, Niels  |d 1981-  |e VerfasserIn  |0 (DE-588)133880184  |0 (DE-627)557868572  |0 (DE-576)276614593  |4 aut 
700 1 |a Frey, Norbert  |e VerfasserIn  |0 (DE-588)141244976  |0 (DE-627)625824075  |0 (DE-576)322969514  |4 aut 
700 1 |a Schmidt, Constanze  |e VerfasserIn  |0 (DE-588)1055852174  |0 (DE-627)792733142  |0 (DE-576)411903721  |4 aut 
773 0 8 |i Enthalten in  |t Basic research in cardiology  |d [Darmstadt u.a.] : Steinkopff, 1937  |g 119(2024), 1, Seite 93-112  |h Online-Ressource  |w (DE-627)253390265  |w (DE-600)1458470-0  |w (DE-576)072283386  |x 1435-1803  |7 nnas  |a Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes 
773 1 8 |g volume:119  |g year:2024  |g number:1  |g pages:93-112  |g extent:20  |a Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes 
856 4 0 |u https://doi.org/10.1007/s00395-023-01022-0  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00395-023-01022-0  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240313 
993 |a Article 
994 |a 2024 
998 |g 1055852174  |a Schmidt, Constanze  |m 1055852174:Schmidt, Constanze  |d 910000  |d 910100  |d 50000  |e 910000PS1055852174  |e 910100PS1055852174  |e 50000PS1055852174  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 19  |y j 
998 |g 141244976  |a Frey, Norbert  |m 141244976:Frey, Norbert  |d 910000  |d 910100  |e 910000PF141244976  |e 910100PF141244976  |k 0/910000/  |k 1/910000/910100/  |p 18 
998 |g 130833525  |a Karck, Matthias  |m 130833525:Karck, Matthias  |d 910000  |d 910200  |e 910000PK130833525  |e 910200PK130833525  |k 0/910000/  |k 1/910000/910200/  |p 16 
998 |g 125001517  |a Warnecke, Gregor  |m 125001517:Warnecke, Gregor  |d 50000  |e 50000PW125001517  |k 0/50000/  |p 15 
998 |g 130213896  |a Meyer, Anna L.  |m 130213896:Meyer, Anna L.  |d 910000  |d 910200  |d 50000  |e 910000PM130213896  |e 910200PM130213896  |e 50000PM130213896  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 14 
998 |g 1023582775  |a Arif, Rawa  |m 1023582775:Arif, Rawa  |d 910000  |d 910200  |d 50000  |e 910000PA1023582775  |e 910200PA1023582775  |e 50000PA1023582775  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 13 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1061215962  |a Blank, Antje  |m 1061215962:Blank, Antje  |d 910000  |d 910100  |e 910000PB1061215962  |e 910100PB1061215962  |k 0/910000/  |k 1/910000/910100/  |p 11 
998 |g 135748178  |a Seeger, Timon  |m 135748178:Seeger, Timon  |d 910000  |d 910100  |e 910000PS135748178  |e 910100PS135748178  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 1323338195  |a Weirauch, Leo  |m 1323338195:Weirauch, Leo  |d 50000  |e 50000PW1323338195  |k 0/50000/  |p 9 
998 |g 1258391805  |a Blochberger, Pablo L.  |m 1258391805:Blochberger, Pablo L.  |d 50000  |e 50000PB1258391805  |k 0/50000/  |p 6 
998 |g 1323337652  |a Herlt, Valerie  |m 1323337652:Herlt, Valerie  |d 50000  |e 50000PH1323337652  |k 0/50000/  |p 5 
998 |g 1189344831  |a Kraft, Manuel  |m 1189344831:Kraft, Manuel  |d 910000  |d 910100  |e 910000PK1189344831  |e 910100PK1189344831  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1055852441  |a Wiedmann, Felix Tobias  |m 1055852441:Wiedmann, Felix Tobias  |d 910000  |d 910100  |e 910000PW1055852441  |e 910100PW1055852441  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1258391082  |a Paasche, Amelie  |m 1258391082:Paasche, Amelie  |d 50000  |e 50000PP1258391082  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1883339758  |e 4499909171 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Paasche","role":"aut","given":"Amelie","display":"Paasche, Amelie"},{"family":"Wiedmann","role":"aut","given":"Felix Tobias","display":"Wiedmann, Felix Tobias"},{"role":"aut","given":"Manuel","family":"Kraft","display":"Kraft, Manuel"},{"family":"Seibertz","given":"Fitzwilliam","role":"aut","display":"Seibertz, Fitzwilliam"},{"display":"Herlt, Valerie","role":"aut","given":"Valerie","family":"Herlt"},{"role":"aut","given":"Pablo L.","family":"Blochberger","display":"Blochberger, Pablo L."},{"display":"Jávorszky, Natasa","family":"Jávorszky","role":"aut","given":"Natasa"},{"display":"Beck, Moritz","family":"Beck","given":"Moritz","role":"aut"},{"role":"aut","given":"Leo","family":"Weirauch","display":"Weirauch, Leo"},{"given":"Timon","role":"aut","family":"Seeger","display":"Seeger, Timon"},{"display":"Blank, Antje","family":"Blank","given":"Antje","role":"aut"},{"given":"Walter E.","role":"aut","family":"Haefeli","display":"Haefeli, Walter E."},{"display":"Arif, Rawa","family":"Arif","given":"Rawa","role":"aut"},{"display":"Meyer, Anna L.","family":"Meyer","role":"aut","given":"Anna L."},{"display":"Warnecke, Gregor","family":"Warnecke","given":"Gregor","role":"aut"},{"given":"Matthias","role":"aut","family":"Karck","display":"Karck, Matthias"},{"display":"Voigt, Niels","role":"aut","given":"Niels","family":"Voigt"},{"given":"Norbert","role":"aut","family":"Frey","display":"Frey, Norbert"},{"family":"Schmidt","role":"aut","given":"Constanze","display":"Schmidt, Constanze"}],"relHost":[{"corporate":[{"role":"isb","display":"Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung"}],"titleAlt":[{"title":"Archiv für Kreislaufforschung"}],"pubHistory":["1.1937 -"],"id":{"zdb":["1458470-0"],"eki":["253390265"],"issn":["1435-1803"]},"part":{"year":"2024","volume":"119","pages":"93-112","extent":"20","text":"119(2024), 1, Seite 93-112","issue":"1"},"origin":[{"publisher":"Steinkopff ; Springer","dateIssuedDisp":"1937-","dateIssuedKey":"1937","publisherPlace":"[Darmstadt u.a.] ; Heidelberg"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe"],"title":[{"subtitle":"official journal of the German Cardiac Society","title_sort":"Basic research in cardiology","title":"Basic research in cardiology"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"253390265","disp":"Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytesBasic research in cardiology"}],"origin":[{"dateIssuedDisp":"03 January 2024","dateIssuedKey":"2024"}],"note":["Gesehen am 13.03.2024"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes","title":"Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes"}],"physDesc":[{"extent":"20 S."}],"recId":"1883339758","name":{"displayForm":["Amelie Paasche, Felix Wiedmann, Manuel Kraft, Fitzwilliam Seibertz, Valerie Herlt, Pablo L. Blochberger, Natasa Jávorszky, Moritz Beck, Leo Weirauch, Timon Seeger, Antje Blank, Walter E. Haefeli, Rawa Arif, Anna L. Meyer, Gregor Warnecke, Matthias Karck, Niels Voigt, Norbert Frey, Constanze Schmidt"]},"id":{"doi":["10.1007/s00395-023-01022-0"],"eki":["1883339758"]}} 
SRT |a PAASCHEAMEACUTEANTIA0320